TSS
VRTX icon

Two Sigma Securities’s Vertex Pharmaceuticals VRTX Stock Holding History

Two Sigma Securities’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-8,400
Closed -$3.91M – 3281
2024
Q3 		$3.91M Buy
8,400
+3,500
+71% +$1.68M 0.07% 345
2024
Q2 		$2.3M Buy
4,900
+700
+17% +$304K 0.03% 657
2024
Q1 		$1.76M Buy
4,200
+500
+14% +$211K 0.02% 823
2023
Q4 		$1.51M Sell
3,700
-2,100
-36% -$776K 0.01% 832
2023
Q3 		$2.02M Sell
5,800
-1,800
-24% -$630K 0.02% 683
2023
Q2 		$2.67M Buy
7,600
+2,100
+38% +$708K 0.04% 481
2023
Q1 		$1.73M Buy
5,500
+900
+20% +$270K 0.03% 579
2022
Q4 		$1.33M Buy
4,600
+3,500
+318% +$1.07M 0.04% 564
2022
Q3 		$318K Buy
+1,100
New +$316K 0.01% 1514
2021
Q1 		– Sell
-6,600
Closed -$1.56M – 1785
2020
Q4 		$1.56M Buy
6,600
+4,600
+230% +$1.06M 0.04% 296
2020
Q3 		$544K Sell
2,000
-2,800
-58% -$772K 0.01% 557
2020
Q2 		$1.39M Buy
4,800
+800
+20% +$217K 0.03% 307
2020
Q1 		$952K Sell
4,000
-14,400
-78% -$3.3M 0.02% 400
2019
Q4 		$4.03M Buy
18,400
+1,900
+12% +$385K 0.03% 467
2019
Q3 		$2.79M Buy
16,500
+11,800
+251% +$2.09M 0.03% 479
2019
Q2 		$862K Sell
4,700
-900
-16% -$157K 0.01% 800
2019
Q1 		$1.03M Sell
5,600
-6,900
-55% -$1.27M 0.01% 550
2018
Q4 		$2.07M Sell
12,500
-20,800
-62% -$3.6M 0.03% 354
2018
Q3 		$6.42M Buy
33,300
+1,600
+5% +$285K 0.04% 316
2018
Q2 		$5.39M Sell
31,700
-11,200
-26% -$1.74M 0.03% 476
2018
Q1 		$6.99M Buy
+42,900
New +$7.01M 0.04% 377

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Two Sigma Securities's VRTX Position: Q2 2026 in Review

Two Sigma Securities increased its Vertex Pharmaceuticals (VRTX) stake by 57% in Q2 2026, buying an estimated $149K and bringing the position to 923 shares worth $458K. The position accounts for 0.04% of the portfolio, ranked #632.

Two Sigma Securities first reported a position in VRTX in Q1 2016 and has held it in 28 quarters since. The position peaked at $14.6M in Q4 2023. 1,758 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Two Sigma Securities held 923 shares of Vertex Pharmaceuticals worth $458K as of Q2 2026.
  • Two Sigma Securities bought 336 Vertex Pharmaceuticals shares in Q2 2026, an estimated $149K.
  • Vertex Pharmaceuticals made up 0.04% of Two Sigma Securities's portfolio in Q2 2026, its #632 holding.
  • Two Sigma Securities first reported a position in Vertex Pharmaceuticals in Q1 2016 and has held it in 28 quarters since.
  • Two Sigma Securities's Vertex Pharmaceuticals position peaked at $14.6M in Q4 2023.
  • 1,758 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.